Grant: A Phase III, radonmized, double-blinded, parallel group, multi centre study to access the efficacy and safety of ZD6474 (ZACTIMA TM) in combination with pemetrexed (Alimta) versus pemetrexed alone in patients with locally-advanced or metastatic (stage IIIB or IV) non-small cell lung cancer (NSCLC) after failure of 1st line anti-cancer therapy
| Project Title |
A Phase III, radonmized, double-blinded, parallel group, multi centre study to access the efficacy and safety of ZD6474 (ZACTIMA TM) in combination with pemetrexed (Alimta) versus pemetrexed alone in patients with locally-advanced or metastatic (stage IIIB or IV) non-small cell lung cancer (NSCLC) after failure of 1st line anti-cancer therapy
|
|---|---|
| Principal Investigator | Ho, James Chung Man (Principal investigator) |
| Co-Investigator(s) |
Dr Wong King Yan Matthew
(Co-Investigator)
Dr Wang Julie Kwan Ling (Co-Investigator) Dr Lam David Chi Leung (Co-Investigator) |
| Funding Year |
2006/2007
|
| Amount |
337838
|
| Panel | Medicine |
| Start Date |
01-02-2007
|
| Expected Completion |
31-08-2009
|
| Status |
On-going
|
| Keywords | locally-advanced, metastatic (stage IIIB or IV) NSCLC |
| Discipline | Respiration, Cancer |
| Grant Type/Funding Scheme | Pharmaceutical Industry - General Award |
| Duration |
31
|
[Coming Soon]